| . | n . | % . | 95% CI . | Mutations . |
|---|---|---|---|---|
| Altogether | 75 | 9.0 | 7.1–11.0 | see below |
| NRTI-associated mutations (including revertants) | 45 | 5.4 | 3.9–7.0 | M41L, A62V, D67N, T69D/N, L74V, V75I, M184V, L210W, K219Q |
| NNRTI-associated mutations | 25 | 3.0 | 1.8–4.2 | K103N, V106A, V108I, Y181C/E, G190A |
| PI-associated mutations | 20 | 2.4 | 1.4–3.4 | D30N, M46I/L, V82A/F/T, I84V, L90M |
| Revertants | 32 | 3.9 | 2.5–5.2 | T215A/C/D/E/L/N/S/V |
| Two-class resistance | 7 | 0.8 | 0.2–1.5 | combinations of the above mentioned |
| Three-class resistance | 4 | 0.5 | 0.01–1.0 | mutations |
| . | n . | % . | 95% CI . | Mutations . |
|---|---|---|---|---|
| Altogether | 75 | 9.0 | 7.1–11.0 | see below |
| NRTI-associated mutations (including revertants) | 45 | 5.4 | 3.9–7.0 | M41L, A62V, D67N, T69D/N, L74V, V75I, M184V, L210W, K219Q |
| NNRTI-associated mutations | 25 | 3.0 | 1.8–4.2 | K103N, V106A, V108I, Y181C/E, G190A |
| PI-associated mutations | 20 | 2.4 | 1.4–3.4 | D30N, M46I/L, V82A/F/T, I84V, L90M |
| Revertants | 32 | 3.9 | 2.5–5.2 | T215A/C/D/E/L/N/S/V |
| Two-class resistance | 7 | 0.8 | 0.2–1.5 | combinations of the above mentioned |
| Three-class resistance | 4 | 0.5 | 0.01–1.0 | mutations |
| . | n . | % . | 95% CI . | Mutations . |
|---|---|---|---|---|
| Altogether | 75 | 9.0 | 7.1–11.0 | see below |
| NRTI-associated mutations (including revertants) | 45 | 5.4 | 3.9–7.0 | M41L, A62V, D67N, T69D/N, L74V, V75I, M184V, L210W, K219Q |
| NNRTI-associated mutations | 25 | 3.0 | 1.8–4.2 | K103N, V106A, V108I, Y181C/E, G190A |
| PI-associated mutations | 20 | 2.4 | 1.4–3.4 | D30N, M46I/L, V82A/F/T, I84V, L90M |
| Revertants | 32 | 3.9 | 2.5–5.2 | T215A/C/D/E/L/N/S/V |
| Two-class resistance | 7 | 0.8 | 0.2–1.5 | combinations of the above mentioned |
| Three-class resistance | 4 | 0.5 | 0.01–1.0 | mutations |
| . | n . | % . | 95% CI . | Mutations . |
|---|---|---|---|---|
| Altogether | 75 | 9.0 | 7.1–11.0 | see below |
| NRTI-associated mutations (including revertants) | 45 | 5.4 | 3.9–7.0 | M41L, A62V, D67N, T69D/N, L74V, V75I, M184V, L210W, K219Q |
| NNRTI-associated mutations | 25 | 3.0 | 1.8–4.2 | K103N, V106A, V108I, Y181C/E, G190A |
| PI-associated mutations | 20 | 2.4 | 1.4–3.4 | D30N, M46I/L, V82A/F/T, I84V, L90M |
| Revertants | 32 | 3.9 | 2.5–5.2 | T215A/C/D/E/L/N/S/V |
| Two-class resistance | 7 | 0.8 | 0.2–1.5 | combinations of the above mentioned |
| Three-class resistance | 4 | 0.5 | 0.01–1.0 | mutations |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
